Lina Elfaki: Anticoagulation Medications – A Critical Component of Patient Safety
Lina Elfaki, Senior clinical pharmacist, shared on LinkedIn:
“Anticoagulation Medications: A Critical Component of Patient Safety
Anticoagulation therapy plays a vital role in preventing and managing thromboembolic disorders across medical and surgical settings. From atrial fibrillation to post-operative care, the safe and effective use of anticoagulants requires careful clinical judgment and monitoring.
Key Anticoagulation Medications:
• Heparin & Low-Molecular-Weight Heparins (Enoxaparin)
• Vitamin K Antagonists (Warfarin)
• Direct Oral Anticoagulants (DOACs): Apixaban, Rivaroxaban, Dabigatran, Edoxaban
Clinical Focus Areas:
• Individualized dosing based on renal function and patient risk
• Monitoring for bleeding and thrombotic complications
• Managing drug–drug and drug–food interactions
• Peri-operative anticoagulation planning
• Patient education to ensure adherence and safety
Interdisciplinary collaboration—especially involving clinical pharmacists—enhances therapeutic outcomes and minimizes preventable adverse events.”
Stay updated on Hemostasis Today.
-
Jun 24, 2026, 06:42Deepthi Krishna: World Blood Donor Day 2026 Celebrations at Rela Hospital
-
Jun 24, 2026, 03:36Ana Pedrero Gil: A New Approach to Post-Tonsillectomy Hemorrhage
-
Jun 24, 2026, 02:59Melissa Hollo: Making Early Anemia Detection the Standard of Care
-
Jun 24, 2026, 02:51Bruno Pougault: The Thin Line Between Bleeding and Clotting
-
Jun 23, 2026, 23:30Shunsuke Iwano: PMDA Introduces Greater Flexibility for Pediatric Factor VIII and IX Development in Japan
-
Jun 23, 2026, 23:05Rounak Dubey: ISBT Academy Session on Agentic AI
-
Jun 23, 2026, 22:59Mohammed Maher Babiker: When ‘Low Platelets’ aren’t Really Low
-
Jun 23, 2026, 22:49Giovanni Merlino: Why Does Stress Hyperglycemia Worsen Stroke Outcomes?
-
Jun 23, 2026, 22:41Tareq Abadl: Coombs Test – The Key to Detecting Immune-Mediated Hemolysis